Individuals Coming Off Weight-Loss Jabs Put On Pounds Four Times Faster Compared to Those on Conventional Diets

New research indicates that patients who come off popular slimming jabs like semaglutide or tirzepatide tend to recover lost weight far faster than those who stop conventional diet and exercise regimens.

Published data in a major medical journal shows that while obese people frequently drop about a fifth of their body weight while using the jabs, the mass returns at an average rate of 0.8 kg per month once they quit.

"Individuals using these treatments must be aware of the potential of rapid weight regain when the therapy is stopped," cautioned expert Dr. Susan Jebb.

Such speed of regain implies a return to starting weight within about one and a half years.

Weighing Approaches

The research, which examined 37 of studies involving thousands of patients, contrasted the outcomes of the injectable medications with other pills.

Researchers emphasize that individuals who shed pounds through lifestyle changes alone usually see a less rapid creep back—perhaps 100 grams monthly—after stopping.

Understanding the Quick Rebound

Nutrition scientists propose the mechanism of the injections accounts for the amplified rebound.

GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which helps regulate appetite.

"Artificially providing the hormone concentrations several times higher than the body's typical production might result in the system to produce less of its own natural hormone, and may also reduce sensitivity to its actions," said Dr. Adam Collins, a dietetics expert.

"Stopping of this medication leads to appetite is unsuppressed, making excessive eating much more probable."

An Ongoing Issue?

Health authorities suggest the injections for individuals with obesity-related health risks, alongside recommended diet and exercise modifications.

Professionals argue that, considering the likelihood of relapse, the treatment is often life-long.

This opinion is supported by drug manufacturers, who note that the results "underscore the long-term nature of excess weight," akin to managing diseases like high blood pressure.

User Accounts

Users who have come off the jabs explain a powerful return of cravings.

"It was like a trigger flipping and you become ravenous," recalled a patient.

This challenge is worsened if patients have not adopted sustainable dietary or behavioural changes during therapy.

Significant Adoption

Survey data show that millions of people in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow.

• Adoption is higher among women than men.
• The 40s and 50s demographic shows the highest usage rates.
• Many access the drugs through private prescriptions rather than public health services.

In conclusion, clinicians stress that while GLP-1 drugs are potent tools for weight loss, they are not a permanent cure and lasting health benefits relies on ongoing lifestyle support.